Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yesterdays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.14 Days to Cover
Off-Exchange Short Volume 28,711,290 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 21.19 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
if ceo decides to drop 10k closer to when the 10Q is due May 15th BEARS are HEAVILY BUCKED 🤣🤣🤣🤑🤑🤑🤑🤑🤑
THINK ABOUT THE YIELD SIGN BUT STILL ALOT OF ACCUMULATION 🤔 BEARS BE READY😉
REMEMBER BEARS THIS IS OTC PINK NOT THE BIG BOARDS NOBODY GIVE A F ABOUT A YIELD SIGN ESPECIALLY WHEN NUMBERS ARE IMPROVING AND DEBT IS BEING PAID AND 400BILLION SHARES BEING BOUGHT BACK GOOD LUCK BEAR SHIT💩💩💩🤣🤑🤑🤑🤑🤑
you been SOLD LOL why still bother lol GO RNVA BEARS ARE SCREWED and they know it we dont need your advice my friend good luck all bears Credibility is gone ceo has done a great job
they say the yield sign on this ticker is starting to look a little bigger every day but over 135MILLION shares traded yesterday only 28mil Darkpool 🤔🤑
alot of Accumulation for a yield sign 🤑
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.14 Days to Cover
Off-Exchange Short Volume 28,711,290 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 21.19 % - source: FINRA (inc. Dark Pool volume)
Who are the BEARS trying to fool not me 🤣🤣🤣🤑🤑🤑🤑🤑🤑🤑
GO RNVA
keep dreaming your psychology is wack 🤣
The BEARS/SHORTS are screwed late filing on OTC PINK mean shit 😉 no worries here my friend keep up the good work BEAR 🐻
Today's Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.20 Days to Cover
Off-Exchange Short Volume 2,813,775 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 35.04 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
Moving forward
We began 2024 with positive operational momentum and seek to build on recent achievements to: (i) further expand our healthcare services offerings in the communities we serve, (ii) consider options to reopen or create value from our closed hospital property, (iii) continue to improve our balance sheet and overall financial condition, and (iv) further reduce litigation and related costs.
Consideration for expansion of healthcare services will include our hospital-based services and behavioral health services provided by Myrtle Recovery Centers, Inc. We continue to evaluate the best ways to create value for Rennova and its shareholders from our investments in InnovaQor, Inc.
We appreciate the support of our shareholders and look forward to increasing shareholder value in 2024.🤑
RNVA Margins 🤑 FACTS 😂😉
Gross margin is 63.10%, with operating and profit margins of 17.96% and 11.66%.
Gross Margin 63.10%
Operating Margin 17.96%
Pretax Margin 14.83%
Profit Margin 11.66%
EBITDA Margin 24.45%
EBIT Margin 22.63%
FCF Margin 18.36%
RNVA Retail Ownership 0007
The Fintel Retail Ownership dataset is created from a large panel of users who share their holdings and transactions with Fintel by linking their broker accounts. The data from these accounts is tracked, aggregated, and published here. We do not share this data with anybody else. Join the panel and receive immediate benefits!
Update Frequency: Daily
See top companies with the most retail ownership.
Date Market Share (%)
2024-04-16 0.0007
Piotroski F-Score for Rennova Health, Inc.
In 2000, Joseph Piotroski published a paper titled "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers." This paper described a method of using data from a company's financial reports to help predict future performance.
The Piotroski F-Score, as it is known, is a 9-point discrete score, where 9 is the best, that ranks companies based on a number of financial factors. To calculate the score, we compare nine factors from the two most recent annual reports. If the change in the factor is "good", then we add one to the score. If the change in the factor is "not good", then we add zero. The following explanations are quoted from the paper.
F-Score
8 /9
No BANKRUPTCY HERE BEARS KEEP DREAMING JUST LIKE THE R/S THEORY 🐻🤣🤣🤣🤣
I remember
RNVA https://www.globenewswire.com/news-release/2023/08/21/2728714/0/en/RENNOVA-HEALTH-INC-PROVIDES-UPDATE-AFTER-FILING-2023-SECOND-QUARTER-FINANCIAL-STATEMENTS.html
Davis then mentioned the fast approaching year end and suggested that the Company could be leaving 2023 with annualized revenues in the $25-30 million range and be profitable. He asked Lagan how he intended to deliver continued growth and where he saw the Company a year from now.
Lagan responded that the current operations plus the behavioral health business should give the Company an annualized run rate of $25-30 million by year end. He went on to remind Davis that there were still some items to be fixed from previous more difficult days but explained the intention to formulate a plan before year end to duplicate the current model in the Jamestown facility in 2024, and stated that if that was successful it would be possible to leave 2024 with annualized revenues of $50-60 million. He confirmed his belief that this was achievable.
Davis ended the interview by asking Lagan what message he would like the Company’s shareholders to take away from the interview. Lagan responded by saying that he believed the Company was now delivering what it had hoped to deliver from work done over the past couple of years and stated a belief that there will be continued success and growth over the next couple of years.
I remember
RNVA https://www.globenewswire.com/news-release/2023/08/14/2724557/0/en/RENNOVA-HEALTH-INC-ANNOUNCES-THE-OPENING-OF-ITS-FIRST-ALCOHOL-AND-DRUG-TREATMENT-FACILITY.html
https://www.globenewswire.com/news-release/2023/06/13/2687244/0/en/RENNOVA-HEALTH-INC-ANNOUNCES-THE-EXPANSION-OF-SERVICES-AT-ITS-BIG-SOUTH-FORK-MEDICAL-CENTER-HOSPITAL-TO-INCLUDE-SWING-BEDS.html
https://ir.rennovahealth.com/press-releases/detail/335/rennova-health-inc-provides-update-after-filing-2022
https://audioboom.com/posts/8251354-rennova-health-rnva-is-featured-on-the-stock-day-podcast
Yesterdays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.27 Days to Cover
Off-Exchange Short Volume 20,269,500 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 76.57 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
About
Currently the CEO of Rennova Health, Inc.
More information at www.rennovahealth.com
Restructured Medytox Solutions, Inc. in mid 2011 and oversaw the growth from less than $1M of sales per year to approximately $57M of reported sales in 2014. Completed merger with CollabRx, Inc. in 2015 to create Nasdaq listed Rennova Health, Inc. (RNVA) in November 2015. Redirected business model from diagnostics to rural hospital development and acquisition in 2017 after significant disruption in the diagnostics sector.
Over 20 years’ experience in the development, restructuring, acquisition and management of startup and small companies in various sectors from alternative energy, oil and gas production and exploration, mining and healthcare. Provides services for both private and public companies. Has an extensive network of legal, accounting and other professional advisers that can be relied on to assist when required. Has numerous funding sources in different sectors to approach if required for qualifying projects. Has secured and structured millions of dollars in funding for various projects, including in excess of $30M in equity funding and approximately $20M of debt in 2015 and 2016 and a further $20M of investment in 2017. Main focus is acquisition and mergers of synergistic business with an emphasis on revenue and a sustainable business model to create long term value.
NOBODY LISTENS TO THE BEARS CEO KNOWS EXACTLY WHAT HE IS DOING THESE BEARS CANT EVEN SLEEP AT NIGHT 😉
WATCH AND LEARN LOOK AT CEO BACK ROUND AND LOOK AT THE BEARS 🐻 LOL 🤣 FOOLS SHOULD HAVE NEVER OVER SHORTED AND BET AGAINST RNVA FOOLS 😉🤑
Rennova Health had revenue of $20.30M in the twelve months ending September 30, 2023, with 113.44% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $3.54M with 25.20% year-over-year growth. In the year 2022, Rennova Health had annual revenue of $13.04M with 304.36% growth.
🤑🤑🤑🤑🤑🤑🤑🤑🤑
P.S i cant wait to see 10-k remember 10Q is due 5/15 🤑🤑🤑🤑🤑🤑🤑 no worries BEARS 🤣🤣😉
The expiration of such a large number of warrants significantly reduces potential dilution to common shareholders,” said Seamus Lagan, CEO of Rennova, “and extending a number of warrants as agreed, preserves the Company’s ability to access additional capital through warrant exercises if market conditions permit.”
LOOK BEARS ARE IN DISBELIEF 🤣🤣🤣 DONT WORRY CUBBIES BEARS THERES MORE COMING PAID BASHERS TIME TO PAY UP SOON 😉
Significant net revenue growth. Growth in net revenues in the third quarter 2023 compared to the prior year’s quarter was 25% reflecting increased patient activity at the hospital and higher reimbursement rates. The Company reported net revenues of approximately $14.8 million for the nine-months ending September 30, 2023 and, therefore, expects to report a significant increase in full year net revenues compared to approximately $13.0 million in net revenues that were reported for 2022.
Debt reduction. Debt from year-end 2022 to September 30, 2023 was reduced from $14.5 million to $11.6 million—a reduction of $2.9 million through debt pay-downs and/or negotiated settlements.
Debt restructuring. We successfully negotiated a debt restructuring with a key institutional lender holding $8.2 million of secured debt in October 2023 to extend the maturity to December 2025 and implement other modifications which waived historical defaults thereby saving default interest in future periods. This restructuring will further improve our balance sheet at December 31, 2023.
2023 Financial Highlights
Significant net revenue growth.
Debt reduction.
Debt restructuring.
InnovaQor, Inc. (OTC: INQR) update.
Established robust inpatient services. 2023 saw inpatient admissions increase by over 75% compared to 2022; this service line was effectively shuttered in late 2020 and early 2021 due to COVID-19 and related matters. In fact, inpatient admissions in 2023 were stronger than in 2019 (pre COVID-19). Vibrant inpatient services mean that most patients who come to our emergency room for treatment no longer need to be transferred to other regional hospitals for inpatient care.
Growth in emergency room and outpatient services. Our ER and outpatient services activity increased by 4% and 8% year-over-year respectively demonstrating the continued, stable demand for such services.
Commenced a swing bed service line. The hospital initiated a swing bed service line—a valuable, profitable service that is helpful to the local communities and other nearby providers.
Opening of a behavioral health treatment facility. We formed a new subsidiary, Myrtle Recovery Centers, Inc., and opened residential and inpatient detox services and outpatient, office-based opiate treatment services at our Big South Fork Medical Center campus in August 2023.
Significant net revenue growth. Growth in net revenues in the third quarter 2023 compared to the prior year’s quarter was 25% reflecting increased patient activity at the hospital and higher reimbursement rates. The Company reported net revenues of approximately $14.8 million for the nine-months ending September 30, 2023 and, therefore, expects to report a significant increase in full year net revenues compared to approximately $13.0 million in net revenues that were reported for 2022.
Debt reduction. Debt from year-end 2022 to September 30, 2023 was reduced from $14.5 million to $11.6 million—a reduction of $2.9 million through debt pay-downs and/or negotiated settlements.
Debt restructuring. We successfully negotiated a debt restructuring with a key institutional lender holding $8.2 million of secured debt in October 2023 to extend the maturity to December 2025 and implement other modifications which waived historical defaults thereby saving default interest in future periods. This restructuring will further improve our balance sheet at December 31, 2023.
No REVERSE SPLIT FACTS 😉🤑
Lagan stated that there were approximately two hundred and fifty billion shares authorized meaning that there was no need for a reverse split for the foreseeable future. He confirmed that the Company currently had no plans to complete a reverse split.
To hear Seamus Lagan’s entire interview, follow the link to the podcast here:
https://audioboom.com/posts/8157101-rennova-health-inc-provides-update-to-the-stock-day-podcast.
We appreciate the support of our shareholders and look forward to increasing shareholder value in 2024.
I truly believe we will see ceo delivering shareholder value in 2024 🤑
Yesterdays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.27 Days to Cover
Off-Exchange Short Volume 20,269,500 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 76.57 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
Today's Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.27 Days to Cover
Off-Exchange Short Volume 20,269,500
shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 76.57 % -
source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
I KNOW WHY THE EXTRA BASHING GO RNVA 😉🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑
could you imagine if ceo releases 10k and 10Q in MAY at the same time 🚀🚀🚀🚀🚀🚀🤑🤑🤑
GO RNVA
let me guess bears if something happens and ceo doesn't file 10k this evening means the SKY IS FALLING rite 😂😂😂 i wont fall for that shit GO RNVA 2024+ paying down debt and profitable 🤑and 400billion share BUYBACK good luck BEARS 🐻
yup No REVERSE SPLIT FACTS 😉🤑
Lagan stated that there were approximately two hundred and fifty billion shares authorized meaning that there was no need for a reverse split for the foreseeable future. He confirmed that the Company currently had no plans to complete a reverse split.
To hear Seamus Lagan’s entire interview, follow the link to the podcast here:
https://audioboom.com/posts/8157101-rennova-health-inc-provides-update-to-the-stock-day-podcast.
We appreciate the support of our shareholders and look forward to increasing shareholder value in 2024.
I truly believe we will see ceo delivering shareholder value in 2024 🤑
2023 Financial Highlights
Significant net revenue growth.
Debt reduction.
Debt restructuring.
InnovaQor, Inc. (OTC: INQR) update.
Established robust inpatient services. 2023 saw inpatient admissions increase by over 75% compared to 2022; this service line was effectively shuttered in late 2020 and early 2021 due to COVID-19 and related matters. In fact, inpatient admissions in 2023 were stronger than in 2019 (pre COVID-19). Vibrant inpatient services mean that most patients who come to our emergency room for treatment no longer need to be transferred to other regional hospitals for inpatient care.
Growth in emergency room and outpatient services. Our ER and outpatient services activity increased by 4% and 8% year-over-year respectively demonstrating the continued, stable demand for such services.
Commenced a swing bed service line. The hospital initiated a swing bed service line—a valuable, profitable service that is helpful to the local communities and other nearby providers.
Opening of a behavioral health treatment facility. We formed a new subsidiary, Myrtle Recovery Centers, Inc., and opened residential and inpatient detox services and outpatient, office-based opiate treatment services at our Big South Fork Medical Center campus in August 2023.
Significant net revenue growth. Growth in net revenues in the third quarter 2023 compared to the prior year’s quarter was 25% reflecting increased patient activity at the hospital and higher reimbursement rates. The Company reported net revenues of approximately $14.8 million for the nine-months ending September 30, 2023 and, therefore, expects to report a significant increase in full year net revenues compared to approximately $13.0 million in net revenues that were reported for 2022.
Debt reduction. Debt from year-end 2022 to September 30, 2023 was reduced from $14.5 million to $11.6 million—a reduction of $2.9 million through debt pay-downs and/or negotiated settlements.
Debt restructuring. We successfully negotiated a debt restructuring with a key institutional lender holding $8.2 million of secured debt in October 2023 to extend the maturity to December 2025 and implement other modifications which waived historical defaults thereby saving default interest in future periods. This restructuring will further improve our balance sheet at December 31, 2023.
I remember
RNVA https://www.globenewswire.com/news-release/2023/08/14/2724557/0/en/RENNOVA-HEALTH-INC-ANNOUNCES-THE-OPENING-OF-ITS-FIRST-ALCOHOL-AND-DRUG-TREATMENT-FACILITY.html
https://www.globenewswire.com/news-release/2023/06/13/2687244/0/en/RENNOVA-HEALTH-INC-ANNOUNCES-THE-EXPANSION-OF-SERVICES-AT-ITS-BIG-SOUTH-FORK-MEDICAL-CENTER-HOSPITAL-TO-INCLUDE-SWING-BEDS.html
https://ir.rennovahealth.com/press-releases/detail/335/rennova-health-inc-provides-update-after-filing-2022
https://audioboom.com/posts/8251354-rennova-health-rnva-is-featured-on-the-stock-day-podcast
i remember
RNVA https://www.globenewswire.com/news-release/2023/08/21/2728714/0/en/RENNOVA-HEALTH-INC-PROVIDES-UPDATE-AFTER-FILING-2023-SECOND-QUARTER-FINANCIAL-STATEMENTS.html
Davis then mentioned the fast approaching year end and suggested that the Company could be leaving 2023 with annualized revenues in the $25-30 million range and be profitable. He asked Lagan how he intended to deliver continued growth and where he saw the Company a year from now.
Lagan responded that the current operations plus the behavioral health business should give the Company an annualized run rate of $25-30 million by year end. He went on to remind Davis that there were still some items to be fixed from previous more difficult days but explained the intention to formulate a plan before year end to duplicate the current model in the Jamestown facility in 2024, and stated that if that was successful it would be possible to leave 2024 with annualized revenues of $50-60 million. He confirmed his belief that this was achievable.
Davis ended the interview by asking Lagan what message he would like the Company’s shareholders to take away from the interview. Lagan responded by saying that he believed the Company was now delivering what it had hoped to deliver from work done over the past couple of years and stated a belief that there will be continued success and growth over the next couple of years.
What do you think 😉🤑
Rennova Health had revenue of $20.30M in the twelve months ending September 30, 2023, with 113.44% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $3.54M with 25.20% year-over-year growth. In the year 2022, Rennova Health had annual revenue of $13.04M with 304.36% growth.
🤑🤑🤑🤑🤑🤑🤑🤑🤑
Will only keep getting better BEAR 🐻
Yesterdays Darkpool
Short Interest 2,934,147 shares - source: FINRA
Short Interest Ratio 0.19 Days to Cover
Off-Exchange Short Volume 11,223,749 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio 63.67 % - source: FINRA (inc. Dark Pool volume)
Finpedia Article Rennova Health
Rennova Health had revenue of $20.30M in the twelve months ending September 30, 2023, with 113.44% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $3.54M with 25.20% year-over-year growth. In the year 2022, Rennova Health had annual revenue of $13.04M with 304.36% growth.
🤑🤑🤑🤑🤑🤑🤑🤑🤑
P.S i cant wait to see 10-k remember 10Q is due 5/15 🤑🤑🤑🤑🤑🤑🤑 no worries BEARS 🤣🤣😉
The expiration of such a large number of warrants significantly reduces potential dilution to common shareholders,” said Seamus Lagan, CEO of Rennova, “and extending a number of warrants as agreed, preserves the Company’s ability to access additional capital through warrant exercises if market conditions permit.”
LOOK BEARS ARE IN DISBELIEF 🤣🤣🤣 DONT WORRY CUBBIES BEARS THERES MORE COMING PAID BASHERS TIME TO PAY UP SOON 😉
Item 1.01 Entry Into a Material Definitive Agreement
On March 20, 2024, Rennova Health, Inc. (the “Company”) and certain institutional holders agreed that, with respect to Series B Warrants (originally issued on March 21, 2017), to acquire 101,350,000,000 shares of common stock, the termination date of such warrants would be extended from March 21, 2024 to December 31, 2025; provided, that (subject to the Company then having an effective registration statement covering the applicable number of shares), if Series B Warrants to acquire the following number of shares of common stock are not exercised in the respective periods below (each, an “Exercise Condition”), the termination date of all of the Series B Warrants shall instead be the date the first such Exercise Condition is not satisfied:
From March 21, 2024 to April 15, 2024 1,350,000,000 shares
From April 16, 2024 to August 30, 2024 2,500,000,000 shares
From August 31, 2024 to December 27, 2024 4,000,000,000 shares
From December 28, 2024 to April 24, 2025 4,000,000,000 shares
From April 25, 2025 to August 29, 202
go back where you came from BEAR been around for years BASHING Good luck 🤣😉
GO RNVA 🤑🤑🤑🤑🤑🤑🤑 BEARS have no credibility here none so causing worry and doubt or BASHING the Company and ceo Psychology games dont work here anymore 🤣🤣🤣🤣🤣
Market Demand
In determining their business model and diversification strategy, it is clear that Rennova Health, Inc. is well positioned to meet not only the needs of its communities but also the evolving demands of the healthcare industry.
According to the American Hospital Association, nearly 20% of Americans live in rural areas and depend on their hospitals as important – and often only – sources of care in their communities. Meanwhile, The U.S. behavioral health market size was valued at USD 76.44 billion in 2021 and is projected to grow from USD 79.69 billion in 2022 to USD 105.14 billion by 2029, according to Fortune Business Insights.
For Rennova, the proven demand for improved access to rural healthcare, as well as the increasing need for behavioral health services, adds both strength and opportunity to their business strategy, representing significant potential for investors and shareholders.
“The expiration of such a large number of warrants significantly reduces potential dilution to common shareholders,” said Seamus Lagan, CEO of Rennova, “and extending a number of warrants as agreed, preserves the Company’s ability to access additional capital through warrant exercises if market conditions permit.”
LOOK BEARS ARE IN DISBELIEF 🤣🤣🤣 DONT WORRY CUBBIES BEARS THERES MORE COMING PAID BASHERS TIME TO PAY UP SOON 😉
Item 1.01 Entry Into a Material Definitive Agreement
On March 20, 2024, Rennova Health, Inc. (the “Company”) and certain institutional holders agreed that, with respect to Series B Warrants (originally issued on March 21, 2017), to acquire 101,350,000,000 shares of common stock, the termination date of such warrants would be extended from March 21, 2024 to December 31, 2025; provided, that (subject to the Company then having an effective registration statement covering the applicable number of shares), if Series B Warrants to acquire the following number of shares of common stock are not exercised in the respective periods below (each, an “Exercise Condition”), the termination date of all of the Series B Warrants shall instead be the date the first such Exercise Condition is not satisfied:
From March 21, 2024 to April 15, 2024 1,350,000,000 shares
From April 16, 2024 to August 30, 2024 2,500,000,000 shares
From August 31, 2024 to December 27, 2024 4,000,000,000 shares
From December 28, 2024 to April 24, 2025 4,000,000,000 shares
From April 25, 2025 to August 29, 202
Rennova Health had revenue of $20.30M in the twelve months ending September 30, 2023, with 113.44% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $3.54M with 25.20% year-over-year growth. In the year 2022, Rennova Health had annual revenue of $13.04M with 304.36% growth.
🤑🤑🤑🤑🤑🤑🤑🤑🤑
P.S i cant wait to see 10-k 🤑
RNVA Margins 🤑 FACTS 😂😉
Gross margin is 63.10%, with operating and profit margins of 17.96% and 11.66%.
Gross Margin 63.10%
Operating Margin 17.96%
Pretax Margin 14.83%
Profit Margin 11.66%
EBITDA Margin 24.45%
EBIT Margin 22.63%
FCF Margin 18.36%
About
Currently the CEO of Rennova Health, Inc.
More information at www.rennovahealth.com
Restructured Medytox Solutions, Inc. in mid 2011 and oversaw the growth from less than $1M of sales per year to approximately $57M of reported sales in 2014. Completed merger with CollabRx, Inc. in 2015 to create Nasdaq listed Rennova Health, Inc. (RNVA) in November 2015. Redirected business model from diagnostics to rural hospital development and acquisition in 2017 after significant disruption in the diagnostics sector.
Over 20 years’ experience in the development, restructuring, acquisition and management of startup and small companies in various sectors from alternative energy, oil and gas production and exploration, mining and healthcare. Provides services for both private and public companies. Has an extensive network of legal, accounting and other professional advisers that can be relied on to assist when required. Has numerous funding sources in different sectors to approach if required for qualifying projects. Has secured and structured millions of dollars in funding for various projects, including in excess of $30M in equity funding and approximately $20M of debt in 2015 and 2016 and a further $20M of investment in 2017. Main focus is acquisition and mergers of synergistic business with an emphasis on revenue and a sustainable business model to create long term value.
NOBODY LISTENS TO THE BEARS CEO KNOWS EXACTLY WHAT HE IS DOING THESE BEARS CANT EVEN SLEEP AT NIGHT 😉
WATCH AND LEARN LOOK AT CEO BACK ROUND AND LOOK AT THE BEARS 🐻 LOL 🤣 FOOLS SHOULD HAVE NEVER OVER SHORTED AND BET AGAINST RNVA FOOLS 😉🤑